This study aims to use the 45 and up cohort to identify patients who had a RBC transfusion and measure the incidence of microchimerism. The 45 and up cohort would be valuable as these patients have transfusions for a range of clinical indications. Since the 45 and up cohort are linked to numerous health related databases, it may also be possible to understand whether patients with microchimerism have any health related outcomes.